Maddy Artunduaga

Maddy Artunduaga

Auto-generated profile, based on publicly available information

Maddy Artunduaga

Pediatric Radiology Division, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
MAMaddy Artunduaga
Maddy Artunduaga
CLC. Amber Liu
C. Amber Liu
CMCara E. Morin
Cara E. Morin
SSSuraj D. Serai
Suraj D. Serai
UUUnni Udayasankar
Unni Udayasankar
MGMichael S. Gee
Michael S. Gee

1 March 2009 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
CRCarlos Santiago Restrepo
Carlos Santiago Restrepo
MAMaddy Artunduaga
Maddy Artunduaga
JCJorge A. Carrillo
Jorge A. Carrillo
ARAura L. Rivera
Aura L. Rivera
POPaulina Ojeda
Paulina Ojeda
SRSantiago E. Rossi
Santiago E. Rossi
To assess patient outcome and imaging findings of patients with pulmonary embolism of fluid silicone. Medical records and imaging examinations of 10 patients with respiratory distress after illicit injection of fluid silicone were reviewed. Population consisted of 8 male (6 male-to-female transsexuals) and 2 female subjects. Average age was 29 years. Most common injection sites were gluteal and trochanteric. Respiratory symptoms developed between 15 minutes and 2 days after silicone injection. Five referred fever, 6 developed adult respiratory distress syndrome, and 2 subsequently died. Alveolar hemorrhage was demonstrated on pathological examination in 6, with silicone vacuoles in the lung parenchyma in 3. Computed tomography demonstrated peripheral ground glass opacities with interlobular septal thickening in all and peripheral airspace disease in 7. Illicit injection of large volumes of fluid silicone for cosmetic purposes is associated with pulmonary embolism and acute alveolar hemorrhage and is associated with a significant mortality.

11 May 2020 in Pediatrics
Verified
Journal Article
Open access
PDF file
DRDevika R. Rao
Devika R. Rao
KMKendra L. Maple
Kendra L. Maple
ADAmy Dettori
Amy Dettori
FAFolashade Afolabi
Folashade Afolabi
JFJenny K.R. Francis
Jenny K.R. Francis
VMVineeta Mittal
Vineeta Mittal
Video Abstract Video Abstract In the United States in 2019, there was an outbreak of electronic cigarette, or vaping, product use–associated lung injury (EVALI). The manifestations of EVALI in adolescents are not well characterized. We describe the diagnosis, evaluation, and management of EVALI in adolescents hospitalized at a tertiary care, university-affiliated children’s hospital. A multidisciplinary committee developed an EVALI algorithm on the basis of guidelines from the Centers for Disease Control and Prevention. A retrospective chart review was conducted on patients diagnosed with EVALI. Descriptive analyses included sociodemographic characteristics, clinical presentation, laboratory and imaging results, pulmonary function testing, oxygen requirements, and clinic follow-up. Thirteen hospitalized adolescents were diagnosed with confirmed or probable EVALI. The majority were female (54%) with a mean age of 15.9 years. Sixty-nine percent of patients presented with respiratory symptoms, whereas gastrointestinal symptoms were prominent in 85% of patients. Vaping Δ-9-tetrahydrocannabinol was reported in 92% of patients, and vaping nicotine was reported in 62% of patients. All had bilateral ground-glass opacities on the chest computed tomography (CT) scan. Treatment with glucocorticoids led to clinical improvement in 11 of 12 patients. Treatment with glucocorticoids led to improvement in both forced expiratory volume in 1 second and forced vital capacity (P < .05). Four patients required home oxygen on the basis of 6-minute walk test results. Diagnosis of EVALI should be suspected on the basis of vaping history and clinical presentation. Glucocorticoid treatment led to an improvement in symptoms and lung function. The 6-minute walk test may help determine oxygen needs at discharge.

9 January 2009 in Emergency Radiology
Verified
Journal Article
Closed access
PDF file
JRJavier M. Romero
Javier M. Romero
MAMaddy Artunduaga
Maddy Artunduaga
NFN. Paola Forero
N. Paola Forero
JDJosser Delgado
Josser Delgado
KSKiran Sarfaraz
Kiran Sarfaraz
PSPamela W. Schaefer
Pamela W. Schaefer

1 May 2020 in Radiology
Verified
Journal Article
Closed access
MAMaddy Artunduaga
Maddy Artunduaga
DRDevika Rao
Devika Rao
JFJonathan Friedman
Jonathan Friedman
JKJeannie K. Kwon
Jeannie K. Kwon
CPCory M. Pfeifer
Cory M. Pfeifer
ELEdward Y. Lee
Edward Y. Lee
Chest imaging findings of electronic cigarette or vaping product use–associated lung injury (EVALI) in pediatric patients were bilateral symmetric ground-glass opacities with subpleural sparing, co... Background Electronic cigarette or vaping product use–associated lung injury (EVALI) is a serious public health concern with substantial morbidity and mortality, particularly in young individuals. ...

29 October 2022 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
MAMaddy Artunduaga
Maddy Artunduaga
MEMeryle Eklund
Meryle Eklund
JBJustine van der Beek
Justine van der Beek
MHMatthew Hammer
Matthew Hammer
ALAnnemieke S. Littooij
Annemieke S. Littooij
GKGeetika Khanna
Geetika Khanna